 |
|
|
|
| ___________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________ |
| ___________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________ |
|
|
 |
|
|
On July 9, 2002, the National Heart, Lung and Blood Institute ("NHLBI"), an agency of the federal government and part of the National Institutes of Health ("NIH"), halted a major clinical trial of the risks and benefits of hormone replacement therapy involving estrogen and progestin — the combination of hormones found in Prempro — in healthy post menopausal women. The 16,600 patient study was abruptly halted after researchers found the risks of taking Prempro outweighed its benefits.
Prempro, which has been prescribed to over 6 million US women, is the leading estrogen-progestin combination hormone replacement therapy drug. Adverse affects linked to Prempro include an increase in strokes, heart attacks, breast cancer, and cardiovascular disease, and a doubling of rates of blood clots. If you took Prempro and have any of these injuries, please obtain a Free Consultation by submitting our online form, or by calling 1-800-543-9859.
Here are some other perscription drugs that have recently been recalled or have been linked to illnesses in users:
|
|
 |
|
|
|
|
|
| __________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________ |
Don’t Hesitate to Contact Robert Peirce & Associates, P.C.
For a Free and Confidential Consultation
Robert Peirce & Associates, P.C.
2500 Gulf Tower, 707 Grant Street, Pittsburgh, PA 15219
P: 1-800-543-9859 F: 412-281-4229 |
| |
| Potential clients: Please be advised that submitting the "free consultation" form through our online system does not commit you to hiring our firm, and does not mean that you have retained an attorney for your potential case. The inquiry form will be reviewed by an attorney, and someone from Robert Peirce & Associates, P.C. will contact you to discuss the facts of your potential case. No attorney-client relationship is formed until a fee agreement is signed. We cannot guarantee the security of this site, and are not responsible for storing sensitive information. |
|
|
